The article in the Canadian Journal of Neurological Sciences discusses a case of paraneoplastic anti-neuronal nuclear antibody type 3 neurologic autoimmunity in a patient with small-cell lung cancer. The patient presented with gait difficulty, paraparesis, and sensory neuropathy, leading to a diagnosis of SCLC. The article highlights the importance of neural antibody testing for suspected central nervous system autoimmunity and discusses the diverse manifestations of ANNA-3/DACH1 neurologic autoimmunity. Treatment for PNS involves managing the underlying malignancy and immunosuppressive therapies, with caution advised when considering immune checkpoint inhibitor therapy in rare cases.